We are live on ! Find out more
CAM

Cormorant Asset Management Portfolio holdings

AUM $1.99B
1-Year Est. Return 737.95%
This Fund
S&P 500
This Quarter Est. Return
-20.78%
1 Year Est. Return
+737.95%
3 Year Est. Return
+5,256.52%
5 Year Est. Return
+13,483.26%
10 Year Est. Return
+564,575.55%
AUM
$664M
AUM Growth
-$172M
Cap. Flow
+$85.8M
Cap. Flow %
12.92%
Top 10 Hldgs %
40.96%
Holding
86
New
4
Increased
14
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$22.2M
2
ALDR
Alder Biopharmaceuticals
ALDR
+$17.1M
3
NKTR icon
Nektar Therapeutics
NKTR
+$15.8M
4
KA
Kineta, Inc. Common Stock
KA
+$13.6M
5
NVRO
NEVRO CORP.
NVRO
+$13M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$52.7M
2
BPMC
Blueprint Medicines
BPMC
+$2.63M

Sector Composition

Rank Sector Weight
1 Healthcare 86.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTEM
76
DELISTED
Molecular Templates, Inc.
MTEM
$460K 0.07%
6,061
– –
PVCT.WS
77
DELISTED
PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS
$440K 0.07%
2,200,000
– –
SRRA
78
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$358K 0.05%
1,329
– –
AGTC
79
DELISTED
Applied Genetic Technologies Corporation
AGTC
$239K 0.04%
17,110
– –
RGLS
80
DELISTED
Regulus Therapeutics
RGLS
$212K 0.03%
255
– –
ADAP
81
DELISTED
Adaptimmune Therapeutics
ADAP
$203K 0.03%
25,000
– –
CLRB icon
82
Cellectar Biosciences
CLRB
$20.5M
$180K 0.03%
18
– –
BPMC
83
DELISTED
Blueprint Medicines
BPMC
– –
-100,000
Closed -$2.63M
DYAX
84
DELISTED
DYAX CORPORATION
DYAX
– –
-1,400,000
Closed -$52.7M
1 2 3
4

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

Cormorant Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Cormorant Asset Management held 86 positions worth $664M, down 21% from $836M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cormorant Asset Management deployed $85.8M of net new capital in Q1 2016, opening 4 new positions and adding to 14 existing holdings. Its largest new stake was Kineta, Inc. Common Stock: 12,333 shares worth $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 80% a quarter earlier.

On the sell side, the most notable exit was DYAX CORPORATION, an estimated $52.7M sold.

  • Cormorant Asset Management's largest Q1 2016 buy was Kineta, Inc. Common Stock: 12,333 shares worth $16.6M.
  • Cormorant Asset Management added most to Sage Therapeutics in Q1 2016, an estimated $22.2M increase.
  • Cormorant Asset Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $52.7M.
  • Cormorant Asset Management's ten largest holdings make up 41% of its $664M portfolio in Q1 2016.
  • Cormorant Asset Management opened 4 new positions and closed 2 in Q1 2016.
  • Cormorant Asset Management's portfolio value fell 21% quarter-over-quarter to $664M.

Based on Cormorant Asset Management's 13F filing for Q1 2016, filed 16 May 2016.